Baillie Gifford - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$6,480,759
-25.4%
1,867,6540.0%0.01%
-14.3%
Q2 2023$8,684,591
+0.6%
1,867,6540.0%0.01%
-12.5%
Q1 2023$8,628,561
-42.9%
1,867,654
-0.1%
0.01%
-50.0%
Q4 2022$15,098,409
+45.6%
1,868,6150.0%0.02%
+45.5%
Q3 2022$10,371,000
+6.7%
1,868,615
+0.2%
0.01%
+10.0%
Q2 2022$9,717,000
-36.7%
1,865,180
-0.2%
0.01%
-9.1%
Q1 2022$15,360,000
-44.4%
1,868,501
+0.7%
0.01%
-26.7%
Q4 2021$27,606,000
-18.6%
1,855,250
+3.4%
0.02%
-16.7%
Q3 2021$33,906,000
+1.7%
1,794,940
+0.0%
0.02%
+12.5%
Q2 2021$33,354,000
-13.6%
1,794,173
+5.8%
0.02%
-27.3%
Q1 2021$38,593,000
+4.8%
1,695,6540.0%0.02%
+10.0%
Q4 2020$36,813,000
+116.0%
1,695,6540.0%0.02%
+66.7%
Q3 2020$17,041,000
+46.4%
1,695,654
+13.0%
0.01%
+33.3%
Q2 2020$11,640,0001,500,0000.01%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders